Phosphinothricin dehydrogenase mutant, genetically engineered bacterium and one-pot multi-enzyme synchronous directed evolution method

Patent metadata

Field	Value
Publication number	US-12152264-B2
Application number	US-202017604412-A
Country	US
Kind code	B2
Filing date	Dec 26, 2020
Priority date	Jun 30, 2020
Publication date	Nov 26, 2024
Grant date	Nov 26, 2024

Abstract

Disclosed are a phosphinothricin dehydrogenase mutant, a recombinant bacterium and a one-pot multi-enzyme synchronous directed evolution method. The phosphinothricin dehydrogenase mutant, with an amino acid sequence as shown in SEQ ID No.1, is obtained by mutating alanine at position 164 to glycine, arginine at position 205 to lysine, and threonine at position 332 to alanine in a phosphinothricin dehydrogenase derived from Pseudomonas fluorescens . The recombinant bacterium is obtained by introducing a gene encoding the phosphinothricin dehydrogenase mutant into a host cell. The host cell can also incorporate a gene encoding a glucose dehydrogenase or a gene encoding a formate dehydrogenase to undergo synchronous directed evolution to achieve double gene overexpression. The one-pot multi-enzyme synchronous directed evolution method of the present invention can screen recombinant bacteria with greatly improved activity. Compared with other catalysis processes such as the transaminase method, the method for preparing L-PPT of the present invention features relatively simple process, high conversion of raw materials of up to 100%, and high stereo selectivity.

First claim

What is claimed is:

1. A phosphinothricin dehydrogenase mutant, wherein the phosphinothricin dehydrogenase mutant has the amino acid sequence of SEQ ID NO: 1.

2. A polynucleotide comprising a nucleotide sequence encoding the phosphinothricin dehydrogenase mutant according to claim 1 .

3. A recombinant bacterium comprising the polynucleotide according to claim 2 .

4. The recombinant bacterium according to claim 3 , wherein the polynucleotide further comprises a nucleotide sequence encoding a glucose dehydrogenase or a formate dehydrogenase.

5. The recombinant bacterium according to claim 4 , wherein the recombinant bacterium comprises a double gene expression vector, and wherein the nucleotide sequence encoding the phosphinothricin dehydrogenase mutant is cloned into a first polyclonal site region of the double gene expression vector, and the nucleotide sequence encoding the glucose dehydrogenase or the formate dehydrogenase is cloned into a second polyclonal site region of the double gene expression vector.

6. The recombinant bacterium according to claim 5 , wherein the nucleotide sequence encoding the glucose dehydrogenase is derived from Exiguobacterium sibiricum , and the length of linking bases between an initiation codon of the nucleotide sequence encoding the glucose dehydrogenase and the corresponding ribosome binding site on a plasmid is 8-10 bp.

7. The recombinant bacterium according to claim 5 , wherein the nucleotide sequence encoding the formate dehydrogenase has the nucleotide sequence as shown in SEQ ID NO: 3.

8. A method for preparing L-phosphinothricin, comprising the step of reacting 2-carbonyl-4-(hydroxymethylphosphinic) butyric acid as a substrate and glucose or ammonium formate as a co-substrate with a catalyst in the presence of an inorganic amino donor and a coenzyme regeneration system to obtain L-phosphinothricin;
wherein the coenzyme regeneration system is a glucose dehydrogenase regeneration system or a formate dehydrogenase regeneration system; and the catalyst comprises the recombinant bacterium according to claim 5 or a phosphinothricin dehydrogenase mutant having the amino acid sequence of SEQ ID NO: 1.

Assignees

• Univ Zhejiang Technology

Inventors

• Xue Yaping
• Cheng Feng
• Li Jumou
• Li Qinghua
• Zheng Yuguo
• Zou Shuping
• Xu Jianmiao

Classifications

• C12Y104/01004

  Glutamate dehydrogenase (NADP+) (1.4.1.4) · CPC title

• C12Y102/01002

  Formate dehydrogenase (1.2.1.2) · CPC title

• C12Y101/01047 Primary

  Glucose 1-dehydrogenase (1.1.1.47) · CPC title

• C12N2800/101

  for bacteria · CPC title

• C12N15/70

  Vectors or expression systems specially adapted for E. coli · CPC title